Building the next generation of ADCs

Using our lightning-fast building block protein technologies and high-throughput phenotypic screening, we make and test next-generation cancer treatments at scale

Get in Touch

Our Solution

5D Combinatorial Drug Discovery: LiliumX™ Platform

Learn More About Our Technology

Faster Design

Rapid drug design using building blocks. Our modular Universal Assembly Platform™ can rapidly and iteratively build libraries of drug candidates from existing components, such as antibody fragments and small molecules.

Powerful Candidates

Due to our “building block” design, we can bring together multiple pieces at once to generate more powerful drug candidates across multiple fields of next-generation antibody engineering, creating unique synergies.

Better Cures

We focus on treating solid tumours with bispecific antibody-drug conjugates. Aiming at two cellular markers at once to differentiate malignant from healthy tissue – this enables us to deliver drugs more specifically and more effectively.

Noteworthy